Menu
Log In Sign Up
Article

peptides cabergoline preventing prolactin from being released by the pituitary gland

Published October Oct 18, 2026 8:16 AM

In the evolving field of biochemical research, investigators often explore various compounds to understand hormonal regulation and receptor sensitivity. One such compound frequently discussed within research circles is peptides cabergoline. While often categorized alongside specialized research compounds, it is essential to clarify that this substance is a dopaminergic medication known primarily for its high affinity for specific receptors.

The Biochemical Profile of Cabergoline

From a research perspective, Cabergoline is recognized as a potent, long-acting dopamine receptor agonist. Specifically, Cabergoline is a selective D2-like dopamine receptor agonist that exhibits high binding affinity for D2, D3, and 5-HT2B receptors. With a CAS number of 81409-90-7, this ergot-derived compound is often utilized in endocrine studies.

When evaluating high-purity Cabergoline, researchers often look for verification via NMR and HPLC analysis to ensure the integrity of the substance. Because Cabergoline is a dopamine receptor agonist, it is frequently studied for its ability to interact with the pituitary gland. Its primary mechanism involves preventing prolactin from being released by the pituitary gland, which is a focal point for those studying endocrine signaling pathways.

Research Context and Observations

In laboratory settings, Cabergoline is a synthetic liquid—or sometimes delivered in tablet form—that has been subject to extensive study since its discovery in 1981. Many investigators use this compound to explore how Cabergoline decreases the production of prolactin, a hormone that controls various physiological functions Amazon Pharmacy: CABERGOLINE 0.5 MG TAB .

In the context of hormone regulatio Cabergoline dostinex 0.5mg per ml x 30ml | Buy Online n, is used to treat hyperprolactinemia in experimental models, as it acts as an effective long-acting dopamine agonist and prolactin inhibitor. While some sources discu Cabergoline (Dostinex) - Uses, Side Effects, and More ss Cabergoline (Dostinex) treats high levels of prolactin, it is important to distinguish between clinical applications and the basic research protocols where scientists might utilize Cabergoline (CAB to observe receptor modulation.

Practical Considerations for Researchers

When sourcing materials for study, professionals often encounter options such as Cabergoline 0.5mg x 30ml or Cabergoline 0.5mg per ml x 30ml solutions. These sterile preparations are intended for research environments. Whether one is sourcing a Cabergoline Tablet 0.5 mg or a liquid variant, the focus remains on the compound’s ab Hyperprolactinemia. Indicated for hyperprolactinemic disorders of either idiopathic or pituitary adenoma origin. Initital: 0.25 mg PO 2x/week.Read more ility to act as a selective D 2 -like dopamine receptor agonis Cabergoline: MedlinePlus Drug Information t.

It is noted in literature that Cabergoline is an ergot derived-dopamine D2-like receptor agonist, which differentiates it from other research peptides. While the term peptide is often Cabergoline (oral route) - Side effects & dosage - Mayo Clinic associated with these studies, it is crucial to note that Cabergoline itself is a small molecule, though it is frequently grouped in the same research catalogs as various peptides.

Safety and Handling

For those managing laboratory inventories, maintaining the purity of CABERGOLINE is vital. Researchers must be aware that while it can be used to treat certain menstrual problems, fertility problems in men and women in clinical settings, its primary role in the lab is to provide a controlle Cabergoline (FCE-21336), an ergot derivative,is a long-acting dopamine agonist and prolactin inhibitor. Quality confirmed by NMR & HPLC. d environment for observing dopamine-mediated responses.

As a dopaminergic medication used in the treatment of high prolactin levels, its potency requires precise handling. The recommended therapeutic dose: 2-3 mg daily is a clinical figure often cited in reference to historical data, but researchers should always consult institutional guidelines regarding the handling of Cabergoline Dostinex and similar compounds.

Conclusion

The study of hormone-modulating compounds remains a cornerstone of modern endocrine research. Whether investigating the nuances of is a tablet treatment used to reduce the production of a hormone called prolactin or analyzing the receptor affinity of this specific agonist, clear data and high-quality materials are essential. By understanding the chemical properties of th Cabergoline dostinex 0.5mg per ml x 30ml | Buy Online is substance, researchers can continue to explore the complex interactions within the endocrine system safely and effectively.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.